Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global AT1 Receptor Antagonists Market Size Growth Rate by Type
1.3.2 Valsartan
1.3.3 Telmisartan
1.3.4 Losartan
1.3.5 Irbesartan
1.3.6 Azilsartan
1.3.7 Olmesartan
1.4 Market Segment by Application
1.4.1 Global AT1 Receptor Antagonists Market Share by Application (2018-2025)
1.4.2 Hypertension
1.4.3 Cardiovascular Diseases
1.4.4 Kidney Diseases
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AT1 Receptor Antagonists Market Size
2.1.1 Global AT1 Receptor Antagonists Revenue 2013-2025
2.1.2 Global AT1 Receptor Antagonists Sales 2013-2025
2.2 AT1 Receptor Antagonists Growth Rate by Regions
2.2.1 Global AT1 Receptor Antagonists Sales by Regions 2013-2018
2.2.2 Global AT1 Receptor Antagonists Revenue by Regions 2013-2018
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 AT1 Receptor Antagonists Sales by Manufacturers
3.1.1 AT1 Receptor Antagonists Sales by Manufacturers 2013-2018
3.1.2 AT1 Receptor Antagonists Sales Market Share by Manufacturers 2013-2018
3.2 Revenue by Manufacturers
3.2.1 AT1 Receptor Antagonists Revenue by Manufacturers (2013-2018)
3.2.2 AT1 Receptor Antagonists Revenue Share by Manufacturers (2013-2018)
3.2.3 Global AT1 Receptor Antagonists Market Concentration Ratio (CR5 and HHI)
3.3 AT1 Receptor Antagonists Price by Manufacturers
3.4 Key Manufacturers AT1 Receptor Antagonists Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into AT1 Receptor Antagonists Market
3.6 Key Manufacturers AT1 Receptor Antagonists Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Valsartan Sales and Revenue (2013-2018)
4.1.2 Telmisartan Sales and Revenue (2013-2018)
4.1.3 Losartan Sales and Revenue (2013-2018)
4.1.4 Irbesartan Sales and Revenue (2013-2018)
4.1.5 Azilsartan Sales and Revenue (2013-2018)
4.1.6 Olmesartan Sales and Revenue (2013-2018)
4.2 Global AT1 Receptor Antagonists Sales Market Share by Type
4.3 Global AT1 Receptor Antagonists Revenue Market Share by Type
4.4 AT1 Receptor Antagonists Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global AT1 Receptor Antagonists Sales by Application
6 North America
6.1 North America AT1 Receptor Antagonists Breakdown Data by Company
6.2 North America AT1 Receptor Antagonists Breakdown Data by Type
6.3 North America AT1 Receptor Antagonists Breakdown Data by Application
6.4 North America AT1 Receptor Antagonists Breakdown Data by Countries
6.4.1 North America AT1 Receptor Antagonists Sales by Countries
6.4.2 North America AT1 Receptor Antagonists Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
7 Europe
7.1 Europe AT1 Receptor Antagonists Breakdown Data by Company
7.2 Europe AT1 Receptor Antagonists Breakdown Data by Type
7.3 Europe AT1 Receptor Antagonists Breakdown Data by Application
7.4 Europe AT1 Receptor Antagonists Breakdown Data by Countries
7.4.1 Europe AT1 Receptor Antagonists Sales by Countries
7.4.2 Europe AT1 Receptor Antagonists Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Company
8.2 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Type
8.3 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Application
8.4 Asia Pacific AT1 Receptor Antagonists Breakdown Data by Countries
8.4.1 Asia Pacific AT1 Receptor Antagonists Sales by Countries
8.4.2 Asia Pacific AT1 Receptor Antagonists Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Thailand
8.4.12 Vietnam
9 Central & South America
9.1 Central & South America AT1 Receptor Antagonists Breakdown Data by Company
9.2 Central & South America AT1 Receptor Antagonists Breakdown Data by Type
9.3 Central & South America AT1 Receptor Antagonists Breakdown Data by Application
9.4 Central & South America AT1 Receptor Antagonists Breakdown Data by Countries
9.4.1 Central & South America AT1 Receptor Antagonists Sales by Countries
9.4.2 Central & South America AT1 Receptor Antagonists Revenue by Countries
9.4.3 Brazil
10 Middle East and Africa
10.1 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Type
10.2 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Application
10.3 Middle East and Africa AT1 Receptor Antagonists Breakdown Data by Countries
10.3.1 Middle East and Africa AT1 Receptor Antagonists Sales by Countries
10.3.2 Middle East and Africa AT1 Receptor Antagonists Revenue by Countries
10.3.3 GCC Countries
10.3.4 Egypt
10.3.5 South Africa
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.1.4 AT1 Receptor Antagonists Product Introduction
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.2.4 AT1 Receptor Antagonists Product Introduction
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.3.4 AT1 Receptor Antagonists Product Introduction
11.3.5 Merck Recent Development
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.4.4 AT1 Receptor Antagonists Product Introduction
11.4.5 Astra Zeneca Recent Development
11.5 Jhonson and Johnson
11.5.1 Jhonson and Johnson Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.5.4 AT1 Receptor Antagonists Product Introduction
11.5.5 Jhonson and Johnson Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.6.4 AT1 Receptor Antagonists Product Introduction
11.6.5 Eli Lilly and Company Recent Development
11.7 Sanofi SA
11.7.1 Sanofi SA Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.7.4 AT1 Receptor Antagonists Product Introduction
11.7.5 Sanofi SA Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.8.4 AT1 Receptor Antagonists Product Introduction
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.9.4 AT1 Receptor Antagonists Product Introduction
11.9.5 Bayer Recent Development
11.10 GSK
11.10.1 GSK Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of AT1 Receptor Antagonists
11.10.4 AT1 Receptor Antagonists Product Introduction
11.10.5 GSK Recent Development
11.11 Teva Pharmaceutical
12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 AT1 Receptor Antagonists Sales Channels
12.2.2 AT1 Receptor Antagonists Distributors
12.3 AT1 Receptor Antagonists Customers
13 Market Forecast
13.1 Global AT1 Receptor Antagonists Sales and Revenue Forecast 2018-2025
13.2 Global AT1 Receptor Antagonists Sales Forecast by Type
13.3 Global AT1 Receptor Antagonists Sales Forecast by Application
13.4 AT1 Receptor Antagonists Forecast by Regions
13.4.1 Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025
13.4.2 Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025
13.5 North America Market Forecast
13.5.1 North America AT1 Receptor Antagonists Forecast by Countries 2018-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe AT1 Receptor Antagonists Forecast by Countries 2018-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.7.2 China
13.7.3 Japan
13.7.4 Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025
13.9.2 GCC Countries
13.9.3 Egypt
13.9.4 South Africa
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure AT1 Receptor Antagonists Product Picture
Table AT1 Receptor Antagonists Key Market Segments
Table Major Manufacturers AT1 Receptor Antagonists Covered in This Report
Table Global AT1 Receptor Antagonists Market Size Growth Rate by Type 2018-2025 (K Units) & (Million US$)
Figure Global AT1 Receptor Antagonists Sales Market Shar by Type 2013-2025
Figure Valsartan Figures
Table Major Manufacturers of Valsartan
Figure Telmisartan Figures
Table Major Manufacturers of Telmisartan
Figure Losartan Figures
Table Major Manufacturers of Losartan
Figure Irbesartan Figures
Table Major Manufacturers of Irbesartan
Figure Azilsartan Figures
Table Major Manufacturers of Azilsartan
Figure Olmesartan Figures
Table Major Manufacturers of Olmesartan
Table Global AT1 Receptor Antagonists Market Share by Application 2018-2025 (K Units)
Figure Hypertension Use Case
Figure Cardiovascular Diseases Use Case
Figure Kidney Diseases Use Case
Figure Other Use Case
Figure AT1 Receptor Antagonists Report Years Considered
Figure Global AT1 Receptor Antagonists Market Size 2013-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Sales 2013-2018 (K Units)
Table Global AT1 Receptor Antagonists Market Size by Regions 2013-2018 (K Units) & (Million US$)
Table Global AT1 Receptor Antagonists Sales by Regions 2013-2018 (K Units)
Table Global AT1 Receptor Antagonists Sales Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Sales Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Sales Market Share by Regions in 2018
Table Global AT1 Receptor Antagonists Revenue by Regions 2013-2018 (Million US$)
Table Global AT1 Receptor Antagonists Revenue Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions 2013-2018
Figure Global AT1 Receptor Antagonists Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global AT1 Receptor Antagonists Sales by Manufacturers (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Manufacturers (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Share by Manufacturers in 2018
Table AT1 Receptor Antagonists Revenue by Manufacturers (2013-2018) (Million USD)
Table AT1 Receptor Antagonists Revenue Share by Manufacturers (2013-2018)
Figure AT1 Receptor Antagonists Value Share by Manufacturers in 2018
Table Global AT1 Receptor Antagonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers AT1 Receptor Antagonists Price (2013-2018) (USD/Unit)
Table Key Manufacturers AT1 Receptor Antagonists Plants/Factories Distribution
Table Key Manufacturers AT1 Receptor Antagonists Area Served
Table Date of Key Manufacturers Enter into AT1 Receptor Antagonists Market
Table Key Manufacturers AT1 Receptor Antagonists Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Valsartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Telmisartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Losartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Irbesartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Azilsartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global Olmesartan Sales and Revenue (2013-2018) (K Units) & (Million US$)
Table Global AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Sales Market Share by Type in 2017
Table Global AT1 Receptor Antagonists Revenue by Type (2013-2018) (Million US$)
Table Global AT1 Receptor Antagonists Revenue Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type (2013-2018)
Figure Global AT1 Receptor Antagonists Revenue Market Share by Type in 2017
Table AT1 Receptor Antagonists Price by Type 2013-2018 (USD/Unit)
Table Global AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Global AT1 Receptor Antagonists Sales Share by Application (2013-2018)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application (2013-2018)
Figure Global Sales AT1 Receptor Antagonists Market Share by Application in 2017
Figure North America AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure North America AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table North America AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure North America AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table North America AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure North America AT1 Receptor Antagonists Market Share by Type in 2018
Table North America AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure North America AT1 Receptor Antagonists Market Share by Application in 2018
Table North America AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 North America AT1 Receptor Antagonists Sales Market Share by Countries
Table North America AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table North America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 North America AT1 Receptor Antagonists Revenue Market Share by Countries
Figure United States AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Canada AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Mexico AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Europe AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Europe AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Europe AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Europe AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Europe AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Type
Table Europe AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Market Share by Application
Table Europe AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Europe AT1 Receptor Antagonists Sales Market Share by Countries
Table Europe AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Europe AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Europe AT1 Receptor Antagonists Revenue Market Share by Countries in 2018
Figure Germany AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure France AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure UK AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Italy AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Russia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Asia Pacific AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Asia Pacific AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Market Share by Type in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure Asia Pacific AT1 Receptor Antagonists Market Share by Application in 2018
Table Asia Pacific AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Sales Market Share by Countries
Table Asia Pacific AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 Asia Pacific AT1 Receptor Antagonists Revenue Market Share by Countries
Figure China AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure China AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Japan AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Japan AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Korea AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Korea AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure India AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure India AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Australia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Australia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Indonesia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Indonesia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Malaysia AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Malaysia AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Philippines AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Philippines AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Thailand AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Thailand AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Vietnam AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Vietnam AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (Million US$)
Figure Central & South America AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Central & South America AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Central & South America AT1 Receptor Antagonists Sales by Company (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Company (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Sales Market Share by Company in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Market Share by Type in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Market Share by Application in 2018
Table Central & South America AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Sales Market Share by Countries in 2018
Table Central & South America AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure Central & South America AT1 Receptor Antagonists Revenue Market Share by Countries in 2018
Figure Brazil AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Brazil AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate 2013-2018 (K Units)
Figure Middle East and Africa AT1 Receptor Antagonists Revenue Growth Rate 2013-2018 (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Sales by Type (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Type (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Type
Table Middle East and Africa AT1 Receptor Antagonists Sales by Application (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Application (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Market Share by Application
Table Middle East and Africa AT1 Receptor Antagonists Sales by Countries (2013-2018) (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Countries
Table Middle East and Africa AT1 Receptor Antagonists Revenue by Countries (2013-2018) (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries (2013-2018)
Figure 2017 Middle East and Africa AT1 Receptor Antagonists Revenue Market Share by Countries
Figure GCC Countries AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure GCC Countries AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure Egypt AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure Egypt AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Figure South Africa AT1 Receptor Antagonists Sales Growth Rate (2013-2018) (K Units)
Figure South Africa AT1 Receptor Antagonists Revenue Growth Rate (2013-2018) (K Units)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Pfizer AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Pfizer AT1 Receptor Antagonists Sales Market Share in Global Market
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Novartis AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Novartis AT1 Receptor Antagonists Sales Market Share in Global Market
Table Novartis Recent Development
Table Merck Company Details
Table Merck Description and Business Overview
Table Merck AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Merck AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Merck AT1 Receptor Antagonists Sales Market Share in Global Market
Table Merck Recent Development
Table Astra Zeneca Company Details
Table Astra Zeneca Description and Business Overview
Table Astra Zeneca AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Astra Zeneca AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Astra Zeneca AT1 Receptor Antagonists Sales Market Share in Global Market
Table Astra Zeneca Recent Development
Table Jhonson and Johnson Company Details
Table Jhonson and Johnson Description and Business Overview
Table Jhonson and Johnson AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Jhonson and Johnson AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Jhonson and Johnson AT1 Receptor Antagonists Sales Market Share in Global Market
Table Jhonson and Johnson Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Description and Business Overview
Table Eli Lilly and Company AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Eli Lilly and Company AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Eli Lilly and Company AT1 Receptor Antagonists Sales Market Share in Global Market
Table Eli Lilly and Company Recent Development
Table Sanofi SA Company Details
Table Sanofi SA Description and Business Overview
Table Sanofi SA AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Sanofi SA AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Sanofi SA AT1 Receptor Antagonists Sales Market Share in Global Market
Table Sanofi SA Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Description and Business Overview
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Bristol-Myers Squibb AT1 Receptor Antagonists Sales Market Share in Global Market
Table Bristol-Myers Squibb Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table Bayer AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table Bayer AT1 Receptor Antagonists Sales Market Share in Global Market
Table Bayer Recent Development
Table GSK Company Details
Table GSK Description and Business Overview
Table GSK AT1 Receptor Antagonists Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2013-2018)
Table GSK AT1 Receptor Antagonists Sales Growth Rate (2013-2018)
Table GSK AT1 Receptor Antagonists Sales Market Share in Global Market
Table GSK Recent Development
Table Teva Pharmaceutical Company Details
Figure AT1 Receptor Antagonists Value Chain
Table AT1 Receptor Antagonists Distributors List
Table AT1 Receptor Antagonists Customers List
Table Global AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units) & (Million US$)
Figure Global AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Revenue Forecast 2018-2025 (Million US$)
Table Global AT1 Receptor Antagonists Sales Forecast by Type 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Type 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Type 2018-2025
Table Global AT1 Receptor Antagonists Sales Forecast by Application 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Application 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Application 2018-2025
Table Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Figure Global AT1 Receptor Antagonists Sales Market Share Forecast by Regions 2018-2025
Table Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Figure Global AT1 Receptor Antagonists Revenue Market Share Forecast by Regions 2018-2025
Table North America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table North America AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table North America AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table North America AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure United States AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Canada AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure MexicoAT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Europe AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Europe AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Europe AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Europe AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure Germany AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure France AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure UK AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Italy AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Russia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Asia Pacific AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Asia Pacific AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Asia Pacific AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure China AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Japan AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Korea AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure India AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Australia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Indonesia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Thailand AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Malaysia AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Philippines AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Figure Vietnam AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Forecast by Countries 2018-2025 (K Units)
Table Central & South America AT1 Receptor Antagonists Sales Market Share Forecast by Countries 2018-2025
Table Central & South America AT1 Receptor Antagonists Revenue Forecast by Countries 2018-2025 (Million US$)
Table Central & South America AT1 Receptor Antagonists Revenue Market Share Forecast by Countries 2018-2025
Figure Brazil AT1 Receptor Antagonists Sales Forecast 2018-2025 (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Regions 2018-2025 (K Units)
Table Middle East and Africa AT1 Receptor Antagonists Sales Market Share Forecast by Regions 2018-2025
Table Middle East and Africa AT1 Receptor Antagonists Revenue Forecast by Regions 2018-2025 (Million US$)
Table Middle East and Africa AT1 Receptor Antagonists Revenue Market Share Forecast by Regions 2018-2025
Figure GCC Countries AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure Egypt AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Figure South Africa AT1 Receptor Antagonists Sales Growth Rate (2016-2025) (K Units)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
【掲載企業】
Pfizer、Novartis、Merck、Astra Zeneca、Jhonson and Johnson、Eli Lilly and Company、Sanofi SA、Bristol-Myers Squibb、Bayer、GSK、Teva Pharmaceutical